ReviewFrontiers in aging neuroscience2023

Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease.

Daoyuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.